在帕金森病中,疼痛,抑郁,认知和运动功能的关联
Nour Alkaduhimi1, Roos Meijer2, Annemarie Vlaar2
1Department of Clinical Neuropsychology, Vrije Universiteit Amsterdam, Amsterdam.
The Journal of neuropsychiatry and clinical neurosciences
|March 16, 2026
概括
运动功能与帕金森病 (PD) 中的抑郁症和认知衰退有关,特别是在姿势不稳定和步行困难 (PIGD) 亚型中. 在这项研究中,疼痛并没有显著影响认知.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,影响运动和非运动功能.
- 患PD有多种亚型,包括震主导 (TD) 和姿势不稳定和步行困难 (PIGD).
- 了解情绪,认知和运动功能之间的相互作用对于PD管理至关重要.
研究的目的:
- 调查抑郁症,疼痛,运动功能和PD认知表现之间的关联.
- 为了确定这些关系是否在PD的TD和PIGD电机亚型之间有所不同.
主要方法:
- 通过神经心理测试评估认知表现.
- 情绪,疼痛和运动功能的测量使用验证的尺度 (例如,医院焦虑和抑郁量表,MDS-UPDRS).
- 对全样本进行的调解分析,并按电机子类型分层分层.
主要成果:
- 在整体PD样本和PIGD组中,运动功能显著介导了抑郁症和认知之间的联系,但不是TD组.
- 疼痛与认知表现没有显著的关联.
- 与TD患者相比,PIGD患者表现出较差的运动功能,更高的抑郁症和较低的认知评分.
结论:
- 运动功能障碍是连接抑郁症状和PD认知缺陷的关键途径,特别是在PIGD亚型中.
- 疼痛似乎没有直接影响PD患者的认知.
- 对PD患者,特别是患有PIGD亚型的PD患者,对运动和非运动症状的联合评估具有临床重要性.
更多相关视频
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
8.4K
10:32Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
56.5K
相关概念视频
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Neural Regulation
44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K
Depressive Disorders: Etiology
832
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
832
Depressive Disorders: MDD and Dysthymia
1.0K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.0K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
